631d
Gefapixant is a new med that Merck is trying to get approved by FDA for release in the US and EU. It was denied in January 2022 for approval but Merck will be resubmitting it. It has been approved in Japan in April 2022 for neurogenic cough use. Hopefully this new drug will be helpful for some.
advertisement
☝ This content is generated by our users and it is not a substitute for professional medical advice. Please consult with your physician before making any medical decision
Want to chat or share? Download the Alike app now and get complete access to Alike.health's unique features.
Bupropion
night sweats
paranoid
Valium
sertraline
palpitations
Anxiety (Including GAD)
Depression
palpitations
Depression
Valium
Bupropion
.svg){kind=small}
.png)
Alike health
Instantly get answers to medical questions with our AI, built from the collective wisdom of our community facing similar experiences
Related Questions